Ensayo clínico

MagDI Australia Study

NCT: NCT06473831 · COMPLETED

ID NCTNCT06473831

EstadoCOMPLETED

Fecha de inicio2024-08-13

Finalización2026-06-25

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-06-25

Last updated2026-09-11

Resumen breve

The objective of the MagDI Australia Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.